ArticleScientific reports2026
Evaluation of phenolic profile and multi-biological activities of Lepista glaucocana extracts optimized by ANN-GA and RSM models.
Article in Scientific reports, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
1 author.
Funding
No grant is acknowledged in the PubMed record.
Abstract
In this study, extraction parameters were optimized using Response Surface Methodology (RSM) and Artificial Neural Network-Genetic Algorithm (ANN-GA) approaches to determine the highest levels of biological activities of Lepista glaucocana (Bres.) Singer. Optimization parameters included temperature, time, and ethanol/water ratio. Subsequently, antioxidant, anticholinesterase, and antiproliferative activities, as well as phenolic contents, of the extracts produced under optimum conditions were determined. The results showed that the ANN-GA optimized extract exhibited significantly higher total antioxidant status (TAS), ferric reducing antioxidant power (FRAP), and DPPH radical scavenging activity compared to the RSM extract. Consequently, total oxidant status (TOS) and oxidative stress index (OSI) values were lower in the ANN-GA extract. ANN-GA extract showed stronger inhibitory effects against acetylcholinesterase (AChE) and butyrylcholinesterase (BChE) enzymes with lower IC50 values compared to RSM extracts. In antiproliferative assays, ANN-GA extract exhibited dose-dependent cytotoxicity against A549 (lung), MCF-7 (breast), and DU-145 (prostate) cancer cell lines. LC-MS/MS analyses revealed higher levels of phenolic compounds such as gallic acid, protocatechuic acid, syringic acid, and 2-hydroxycinnamic acid in the ANN-GA optimized extract. Consequently, the ANN-GA model was found to be a more efficient optimization tool than RSM. It was also determined that L. glaucocana may be a promising natural source of multifunctional bioactive compounds with antioxidant, anticholinesterase-related, and in vitro antiproliferative potential.
Indexed as
Identifiers
What Socratic holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the Socratic graph.